FOLLOW US

  • facebook
  • twitter
Mon

March 16, 2026

Eli Lilly to buy Orna Therapeutics

America February 9, 2026

Eli Lilly to Buy Orna Therapeutics in $2.4B RNA Bet

In a move that underscores Big Pharma’s race to harness next-generation genetic medicine, Eli Lilly to buy Orna Therapeutics in…

By Rachel Moore

Paul Hastings Manages IPO

America November 3, 2023

Paul Hastings Manages IPO for Lexeo Therapeutics: A Genetic Medicine Game-Changer

In a heart-pounding financial feat, Lexeo Therapeutics Inc., a trailblazing gene-therapy focused biotechnology firm, has unleashed a torrent of excitement…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter